v3.26.1
Discontinued Operations - Reconciliation of Discontinued Operations (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Costs and expenses:    
Net income from discontinued operations, net of tax $ (1,392) $ (9,171)
Discontinued Operations Disposed of by Sale    
Discontinued Operations    
Net revenue (899)  
Costs and expenses:    
Cost of goods sold 55  
Selling, general and administrative 50  
Total costs and expenses 105  
Income from operations (1,004)  
Loss on Sale Transactions, net (388)  
Net income from discontinued operations before income taxes (1,392)  
Net income from discontinued operations, net of tax (1,392)  
Discontinued Operations Disposed of by Sale | YUSIMRY immunology franchise    
Discontinued Operations    
Net revenue 2  
Discontinued Operations Disposed of by Sale | CIMERLI ophthalmology franchise    
Discontinued Operations    
Net revenue $ (54)  
Assets Held For Sale    
Discontinued Operations    
Net revenue   32,134
Costs and expenses:    
Cost of goods sold   19,349
Selling, general and administrative   7,178
Total costs and expenses   26,527
Income from operations   5,607
Interest expense   (2,997)
Other income (expense), net   (11,781)
Net income from discontinued operations before income taxes   (9,171)
Net income from discontinued operations, net of tax   (9,171)
Assets Held For Sale | YUSIMRY immunology franchise    
Discontinued Operations    
Net revenue   43
Assets Held For Sale | CIMERLI ophthalmology franchise    
Discontinued Operations    
Net revenue   $ 629